Financial statements Imperio Laboratories

Balance sheet of Imperio Laboratories

Company age:
Age:
9 y. 5 m. 8 d.
Share capital:
Share capital:
5 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of IMPERIO LABORATORIES

Year
2018
2019
2020
2021
2022
2023
Total assets 607 098,34 434 030,99 341 850,57 304 544,85 273 749,33 310 181,21
A. Fixed assets 519 972,60 398 573,86 312 783,38 248 294,00 194 228,84 91 956,16
B. Current assets 87 125,74 35 457,13 29 067,19 29 067,19 79 520,49 218 225,05
C. Share capital contributions (basic funds) - - - - - -
D. Own shares (stocks) - - - - - -
Total liabilities 607 098,34 434 030,99 341 850,57 304 544,85 273 749,33 310 181,21
A. Equity 377 290,44 176 463,84 188 411,37 254 214,26 229 959,24 291 154,23
B. Liabilities and provisions for liabilities 229 807,90 257 567,15 153 439,20 50 330,59 43 790,09 19 026,98
I. Long-term liabilities - - - - - -
II. Short-term liabilities - - - - - -
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.